Posaconazole as first line treatment for disseminated zygomycosis.
We describe the first case report of posaconazole use as first line agent in the treatment of disseminated zygomycosis with prosthetic hip joint and pulmonary involvement due to Rhizopus microsporus. This infection occurred in a heavily immunosuppressed patient with systemic lupus erythematosus.
Peel
Trisha
T
Daffy
John
J
Thursky
Karin
K
Stanley
Peter
P
Buising
Kirsty
K
D000935:Antifungal Agents / Q000627:therapeutic use*; D005260:Female; D006622:Hip Prosthesis; D006801:Humans; D016867:Immunocompromised Host; D008172:Lung Diseases, Fungal / Q000188:drug therapy; D008180:Lupus Erythematosus, Systemic / Q000150:complications; D008875:Middle Aged; D016459:Prosthesis-Related Infections / Q000188:drug therapy; D012233:Rhizopus / Q000302:isolation & purification*; D014230:Triazoles / Q000627:therapeutic use*; D020096:Zygomycosis / Q000188:drug therapy*
D000935:Antifungal Agents; D014230:Triazoles; C101425:posaconazole